Lucy Scientific Discovery Inc. (LSDIF)
OTCMKTS: LSDIF · Delayed Price · USD
0.200
0.00 (0.00%)
Jul 2, 2024, 3:38 PM EDT - Market closed
Company Description
Lucy Scientific Discovery Inc., an early stage psychotropics contract manufacturing company, engaged in the research, manufacturing, and commercialization of psychedelic products.
The company offers biological raw materials, active pharmaceutical ingredients (APIs), and finished biopharmaceutical products.
It also develops and produces highly controlled agricultural grow environments for plant manufacturing and replication applications.
The company was formerly known as Hollyweed North Cannabis Inc. and changed its name to Lucy Scientific Discovery Inc. in May 2021.
Lucy Scientific Discovery Inc. was incorporated in 2017 and is headquartered in Victoria, Canada.
Lucy Scientific Discovery Inc.
| Country | British Columbia, Canada |
| Founded | 2017 |
| IPO Date | Feb 9, 2023 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2 |
Contact Details
Address: 301-1321 Blanshard Street Victoria, A1 V8W 0B6 British Columbia, Canada | |
| Phone | 778-410-5195 |
Stock Details
| Ticker Symbol | LSDIF |
| Exchange | OTCMKTS |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001865127 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Richard D. Nanula | Chief Executive Officer and Executive Chair |
| Brian Zasitko C.A., CPA | Chief Financial Officer |
| Scott Michael Reeves L.L.B. | Corporate Secretary and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 1, 2024 | 8-K | Current Report |
| May 28, 2024 | 8-K | Current Report |
| May 15, 2024 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| May 9, 2024 | 8-K | Current Report |
| Apr 23, 2024 | 8-K | Current Report |
| Mar 12, 2024 | 8-K | Current Report |
| Mar 1, 2024 | 424B3 | Prospectus |
| Feb 27, 2024 | EFFECT | Notice of Effectiveness |
| Feb 27, 2024 | 8-K | Current Report |
| Feb 23, 2024 | 8-K | Current Report |